ICU Equipment in Pennsylvania

Pronia Medical Systems develops GlucoCare, an FDA-cleared insulin dosing calculator software designed for critical care settings. GlucoCare is a web-based medical device that runs on standard browsers within hospital intranets or via cloud deployment, requiring minimal IT infrastructure for installation. The system implements the Yale Protocol—a customized, patient-response-based insulin dosing algorithm that accounts for current blood glucose, prior glucose trends, measurement intervals, and current insulin rate to calculate real-time insulin resistance and recommend safe dose adjustments. Clinical evidence demonstrates GlucoCare achieves hypoglycemia rates below 0.2% for readings <70 mg/dL while maintaining target glucose ranges. The platform supports multiple protocol variants (GlucoCare-140, GlucoCare-160) with configurable target ranges (100–160 mg/dL) and allows clinician overrides with quality assurance documentation. Built-in analytics provide unit-level and individual-user tracking for glucose control compliance and protocol adherence, enabling continuous quality improvement. GlucoCare integrates with hospital EMR systems and has been validated in peer-reviewed literature (Diabetes, Technology and Therapeutics). The company partners with EHR platforms including Cerner-based systems. Intended users are primarily nurses and critical care teams in hospital ICU settings managing patients requiring insulin infusions.

DRW Medical manufactures specialized respiratory and monitoring equipment for neonatal and pediatric intensive care settings. The company's primary product lines focus on non-invasive ventilation support and patient safety monitoring for infants. NAPA Monitoring systems (LP-15 and LP-35 monitors) are designed to provide real-time pressure and waveform data during Bubble CPAP (continuous positive airway pressure) and Nasal High Flow (NHF) therapy, preventing complications such as pneumothorax and desaturation events caused by disconnects or inadequate pressure delivery. The NAPA LP-35, their newest offering, features enhanced capabilities including real-time waveforms and touchscreen operation, paired with their flow-pro Dual Lumen Cannula to monitor dynamic resultant pressures and optimize safe flow rates in high-flow nasal cannula therapy. The Exsalta Smart Suction system represents innovation in endotracheal tube clearance, delivering suction efficacy comparable to wall suction while minimizing negative lung pressure—a critical consideration in neonatal care. DRW Medical serves a broad network of U.S. hospitals and health systems, including major academic medical centers, children's hospitals, and regional hospital networks across all 50 states. Their customer base includes institutions such as Duke University Hospital, Nationwide Children's Hospital, Robert Wood Johnson, and numerous Advent Health and Wellstar facilities. The company exhibits strong market penetration in neonatal and pediatric critical care, positioning products for clinicians managing complex airway and respiratory management in vulnerable patient populations.